Interventional Care

We notice that you are visiting us from . This site only services US-based visitors. Would you like to visit the site that is appropriate for your location?
Up to 30 percent of adults are nasally colonized with S. aureus. S. aureus accounts for over 30% of SSIs. Nasal colonization with these bacteria increases the patient risk of developing an SSI by 9 times. To help reduce this risk, Povidone-Iodine is used as it is a broad spectrum antiseptic that has been proven effective in reducing both S. aureus. It offers an added advantage over the widely-used nasal antibiotic, mupirocin, in that there is no known bacterial resistance to it, thereby supporting antibiotic stewardship within the healthcare environment.